NICE Technology Appraisal 420: Ticagrelor for preventing atherothrombotic events after myocardial infarction
Disclaimer: Information intended for healthcare professionals only. The guidance relates to the 60mg dose of ticagrelor. The production and printing of this Guidelines Technology Appraisal Card has been initiated and funded by AstraZeneca. The prescribing information for ticagrelor can be found on page 2 of this item.
Job code: GB-3566
Date of preparation: January 2017
Management of asthma in adults over 65 years of age
Development group: Gruffydd-Jones, McArthur, Murphy, Russell & Wise. This management algorithm was developed by a multidisciplinary expert panel: Gruffydd-Jones K et al with the support of a grant from Teva UK Limited.